Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.99 USD | +1.36% | +11.57% | +98.01% |
04-17 | RBC Raises Price Target on Nuvation Bio to $5 From $4, Keeps Outperform, Speculative Risk | MT |
04-10 | Nuvation Bio Closes Acquisition of AnHeart Therapeutics | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+98.01% | 775M | |
+0.17% | 42.86B | |
+10.92% | 42.74B | |
+44.30% | 41.36B | |
-6.20% | 27.68B | |
+5.23% | 25.15B | |
-24.79% | 18.63B | |
+26.69% | 12.37B | |
-3.13% | 11.92B | |
+6.57% | 11.21B |
- Stock Market
- Equities
- NUVB Stock
- News Nuvation Bio Inc.
- Wedbush Adjusts Nuvation Bio Price Target to $17 From $23, Maintains Outperform Rating